| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Advances in Brief |
Canji, Inc., San Diego, California 92121
Genetic alterations in the MMAC1 tumor suppressor gene (also referred to as PTEN or TEP1) occur in several types of human cancers including glioblastoma. Growth suppression induced by overexpression of MMAC1 in cells with mutant MMAC1 alleles is thought to be mediated by the inhibition of signaling through the phosphatidylinositol 3-kinase pathway. However, the exact biochemical mechanisms by which MMAC1 exerts its growth-inhibitory effects are still unknown. Here we report that recombinant adenovirus-mediated overexpression of MMAC1 in three different MMAC1-mutant glioblastoma cell lines blocked progression from G0/G1 to S phase of the cell cycle. Cell cycle arrest correlated with the recruitment of the cyclin-dependent kinase (CDK) inhibitor, p27Kip1, to cyclin E immunocomplexes, which resulted in a reduction in CDK2 kinase activities and a decrease in levels of endogenous phosphorylated retinoblastoma protein. CDK4 kinase activities were unaffected, as were the levels of the CDK inhibitor p21Cip1 present in cyclin E immunocomplexes. Therefore, overexpression of MMAC1 via adenovirus-mediated gene transfer suppresses tumor cell growth through cell cycle inhibitory mechanisms, and as such, represents a potential therapeutic approach to treating glioblastomas.
This article has been cited by other articles:
|
|
 |
|
  V. Dave, S. E. Wert, T. Tanner, A. R. Thitoff, D. E. Loudy, and J. A. Whitsett Conditional Deletion of Pten Causes Bronchiolar Hyperplasia Am. J. Respir. Cell Mol. Biol., March 1, 2008; 38(3): 337 - 345. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. S P Tan and S. Kaye Ovarian clear cell adenocarcinoma: a continuing enigma J. Clin. Pathol., April 1, 2007; 60(4): 355 - 360. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Tabu, A. Ohnishi, Y. Sunden, T. Suzuki, M. Tsuda, S. Tanaka, T. Sakai, K. Nagashima, and H. Sawa A novel function of OLIG2 to suppress human glial tumor cell growth via p27Kip1 transactivation. J. Cell Sci., April 1, 2006; 119(Pt 7): 1433 - 1441. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Yao, C. L. Alexander, J. A. Quinn, M. J. Porter, H. Wu, and D. A. Greenhalgh PTEN Loss Promotes rasHa-Mediated Papillomatogenesis via Dual Up-Regulation of AKT Activity and Cell Cycle Deregulation but Malignant Conversion Proceeds via PTEN-Associated Pathways Cancer Res., February 1, 2006; 66(3): 1302 - 1312. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J.-L. Liu, X. Sheng, Z. K. Hortobagyi, Z. Mao, G. E. Gallick, and W. K. A. Yung Nuclear PTEN-Mediated Growth Suppression Is Independent of Akt Down-Regulation Mol. Cell. Biol., July 15, 2005; 25(14): 6211 - 6224. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Q. Ding, J. R. Grammer, M. A. Nelson, J.-L. Guan, J. E. Stewart Jr., and C. L. Gladson p27Kip1 and Cyclin D1 Are Necessary for Focal Adhesion Kinase Regulation of Cell Cycle Progression in Glioblastoma Cells Propagated in Vitro and in Vivo in the Scid Mouse Brain J. Biol. Chem., February 25, 2005; 280(8): 6802 - 6815. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. I. Fernando and J. Wimalasena Estradiol Abrogates Apoptosis in Breast Cancer Cells through Inactivation of BAD: Ras-dependent Nongenomic Pathways Requiring Signaling through ERK and Akt Mol. Biol. Cell, July 1, 2004; 15(7): 3266 - 3284. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Mahimainathan and G. G. Choudhury Inactivation of Platelet-derived Growth Factor Receptor by the Tumor Suppressor PTEN Provides a Novel Mechanism of Action of the Phosphatase J. Biol. Chem., April 9, 2004; 279(15): 15258 - 15268. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. A. Orchiston, D. Bennett, N. R. Leslie, R. G. Clarke, L. Winward, C. P. Downes, and S. T. Safrany PTEN M-CBR3, a Versatile and Selective Regulator of Inositol 1,3,4,5,6-Pentakisphosphate (Ins(1,3,4,5,6)P5): EVIDENCE FOR Ins(1,3,4,5,6)P5 AS A PROLIFERATIVE SIGNAL J. Biol. Chem., January 9, 2004; 279(2): 1116 - 1122. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Radu, V. Neubauer, T. Akagi, H. Hanafusa, and M.-M. Georgescu PTEN Induces Cell Cycle Arrest by Decreasing the Level and Nuclear Localization of Cyclin D1 Mol. Cell. Biol., September 1, 2003; 23(17): 6139 - 6149. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Shi, J. Gera, L. Hu, J.-h. Hsu, R. Bookstein, W. Li, and A. Lichtenstein Enhanced Sensitivity of Multiple Myeloma Cells Containing PTEN Mutations to CCI-779 Cancer Res., September 1, 2002; 62(17): 5027 - 5034. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J Mad'arova, M Lukesova, A Hlobilkova, M Strnad, B Vojtesek, R Lenobel, M Hajduch, P G Murray, S Perera, and Z Kolar Synthetic inhibitors of CDKs induce different responses in androgen sensitive and androgen insensitive prostatic cancer cell lines Mol. Pathol., August 1, 2002; 55(4): 227 - 234. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. B. Knobbe, A. Merlo, and G. Reifenberger Pten signaling in gliomas Neuro-oncol, July 1, 2002; 4(3): 196 - 211. [Abstract] [PDF]
|
|
|
|
 |
|
 S. Sun and B. M. Steinberg PTEN is a negative regulator of STAT3 activation in human papillomavirus-infected cells J. Gen. Virol., June 1, 2002; 83(7): 1651 - 1658. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. A. Davies, S. J. Kim, N. U. Parikh, Z. Dong, C. D. Bucana, and G. E. Gallick Adenoviral-mediated Expression of MMAC/PTEN Inhibits Proliferation and Metastasis of Human Prostate Cancer Cells Clin. Cancer Res., June 1, 2002; 8(6): 1904 - 1914. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. P. Ermoian, C. S. Furniss, K. R. Lamborn, D. Basila, M. S. Berger, A. R. Gottschalk, M. K. Nicholas, D. Stokoe, and D. A. Haas-Kogan Dysregulation of PTEN and Protein Kinase B Is Associated with Glioma Histology and Patient Survival Clin. Cancer Res., May 1, 2002; 8(5): 1100 - 1106. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. A. Walter, M. A. Hossain, C. Luddy, N. Goel, T. E. Reznik, and J. Laterra Scatter Factor/Hepatocyte Growth Factor Stimulation of Glioblastoma Cell Cycle Progression through G1 Is c-Myc Dependent and Independent of p27 Suppression, Cdk2 Activation, or E2F1-Dependent Transcription Mol. Cell. Biol., April 15, 2002; 22(8): 2703 - 2715. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Murillo, H. Huang, L. J. Schmidt, D. I. Smith, and D. J. Tindall Role of PI3K Signaling in Survival and Progression of LNCaP Prostate Cancer Cells to the Androgen Refractory State Endocrinology, November 1, 2001; 142(11): 4795 - 4805. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
X. Zhu, C.-H. Kwon, P. W. Schlosshauer, L. H. Ellenson, and S. J. Baker PTEN Induces G1 Cell Cycle Arrest and Decreases Cyclin D3 Levels in Endometrial Carcinoma Cells Cancer Res., June 1, 2001; 61(11): 4569 - 4575. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Kurose, X.-P. Zhou, T. Araki, S. A. Cannistra, E. R. Maher, and C. Eng Frequent Loss of PTEN Expression Is Linked to Elevated Phosphorylated Akt Levels, but Not Associated with p27 and Cyclin D1 Expression, in Primary Epithelial Ovarian Carcinomas Am. J. Pathol., June 1, 2001; 158(6): 2097 - 2106. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Matsushima-Nishiu, M. Unoki, K. Ono, T. Tsunoda, T. Minaguchi, H. Kuramoto, M. Nishida, T. Satoh, T. Tanaka, and Y. Nakamura Growth and Gene Expression Profile Analyses of Endometrial Cancer Cells Expressing Exogenous PTEN Cancer Res., May 1, 2001; 61(9): 3741 - 3749. [Abstract] [Full Text]
|
|
|
|
 |
|
 J.-i. Hisatake, J. O'Kelly, M. R. Uskokovic, S. Tomoyasu, and H. P. Koeffler Novel vitamin D3 analog, 21-(3-methyl-3-hydroxy-butyl)-19-nor D3, that modulates cell growth, differentiation, apoptosis, cell cycle, and induction of PTEN in leukemic cells Blood, April 15, 2001; 97(8): 2427 - 2433. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L.-P. Weng, J. L. Brown, and C. Eng PTEN coordinates G1 arrest by down-regulating cyclin D1 via its protein phosphatase activity and up-regulating p27 via its lipid phosphatase activity in a breast cancer model Hum. Mol. Genet., March 1, 2001; 10(6): 599 - 604. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. R. Gottschalk, D. Basila, M. Wong, N. M. Dean, C. H. Brandts, D. Stokoe, and D. A. Haas-Kogan p27Kip1 Is Required for PTEN-induced G1 Growth Arrest Cancer Res., March 1, 2001; 61(5): 2105 - 2111. [Abstract] [Full Text]
|
|
|
|
|
|
V. Taylor, M. Wong, C. Brandts, L. Reilly, N. M. Dean, L. M. Cowsert, S. Moodie, and D. Stokoe 5' Phospholipid Phosphatase SHIP-2 Causes Protein Kinase B Inactivation and Cell Cycle Arrest in Glioblastoma Cells Mol. Cell. Biol., September 15, 2000; 20(18): 6860 - 6871. [Abstract] [Full Text]
|
|
|
|
 |
|
 I. U. Ali Gatekeeper for Endometrium: the PTEN Tumor Suppressor Gene J Natl Cancer Inst, June 7, 2000; 92(11): 861 - 863. [Full Text] [PDF]
|
|
|
|
 |
|
 A. M. Mirza, A. D. Kohn, R. A. Roth, and M. McMahon Oncogenic Transformation of Cells by a Conditionally Active Form of the Protein Kinase Akt/PKB Cell Growth Differ., June 1, 2000; 11(6): 279 - 292. [Abstract] [Full Text]
|
|
|
|
|
|
I. U. Ali, L. M. Schriml, and M. Dean Mutational Spectra of PTEN/MMAC1 Gene: a Tumor Suppressor With Lipid Phosphatase Activity J Natl Cancer Inst, November 17, 1999; 91(22): 1922 - 1932. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Tamura, J. Gu, H. Tran, and K. M. Yamada PTEN Gene and Integrin Signaling in Cancer J Natl Cancer Inst, November 3, 1999; 91(21): 1820 - 1828. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L.-P. Weng, W. M. Smith, P. L. M. Dahia, U. Ziebold, E. Gil, J. A. Lees, and C. Eng PTEN Suppresses Breast Cancer Cell Growth by Phosphatase Activity-dependent G1 Arrest followed by Cell Death Cancer Res., November 1, 1999; 59(22): 5808 - 5814. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |
